DiaSys Corporation Stock

Equities

DYXC

US2528381070

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 10:28:52 2024-04-25 EDT 5-day change 1st Jan Change
0.00002 USD -90.00% Intraday chart for DiaSys Corporation -.--% -98.00%
Sales 2006 1.69M 2.3M Sales 2007 1.68M 2.29M Capitalization 2.83M 3.86M
Net income 2006 -1M -1.36M Net income 2007 - 0 EV / Sales 2006 2.7 x
Net Debt 2006 302K 411K Net Debt 2007 594K 810K EV / Sales 2007 2.04 x
P/E ratio 2006
-3.78 x
P/E ratio 2007
-3 x
Employees -
Yield 2006 *
-
Yield 2007
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
More insiders
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
More about the company